top of page
Our Team.
The management team is highly accomplished in pharmaceutical development and in creating
significant enterprise value. In particular, the CEO, Chris Prior, Ph.D., has created liquidity opportunities
with his last four companies, two M&As and two IPOs, while the CMO, Daniel Vlock, M.D., has also built
and sold a biopharm company. Together, exits achieved by these two executives exceed $1 Billion.
Chris Prior, Ph.D.
CEO & Chairman
Daniel Vlock, MD
Chief Medical Officer
Jeff Davidson B.S. Ch. E., MBA
Chief Operating Officer
James Sharpe, BS Chem, MBA
Chief Business Officer
Buckner Brown MBA, CPA
Chief Financial Officer
James Adair, Ph.D.
Chief Science Officer
Mark Kester
Chief Technology Officer
bottom of page